AGT | Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM1L | Absent in melanoma 1-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AJAP1 | Adherens junctions associated protein 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
AJUBA | Ajuba LIM protein | Cancer-related genes Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AK7 | Adenylate kinase 7 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AKAP5 | A kinase (PRKA) anchor protein 5 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AL008723.1 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
AL021546.6 | Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial {ECO:0000313|Ensembl:ENSP00000229384} | Predicted intracellular proteins
| | | | | Tissue enhanced |
AL109927.1 | HCG2032222 {ECO:0000313|EMBL:EAX07737.1}; PRO2047 {ECO:0000313|EMBL:AAF22035.1} | Predicted intracellular proteins
| | | | | Tissue enhanced |
AL513478.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
AL589743.1 | | Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALDOC | Aldolase C, fructose-bisphosphate | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALG1L | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALG1L2 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Predicted membrane proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALMS1 | Alstrom syndrome 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALOX15 | Arachidonate 15-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALOX15B | Arachidonate 15-lipoxygenase, type B | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALPPL2 | Alkaline phosphatase, placental-like 2 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALS2CL | ALS2 C-terminal like | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALX1 | ALX homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ALX3 | ALX homeobox 3 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ALX4 | ALX homeobox 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AMICA1 | Adhesion molecule, interacts with CXADR antigen 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
AMOT | Angiomotin | Predicted intracellular proteins
| | | | | Tissue enhanced |
AMZ1 | Archaelysin family metallopeptidase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANGPTL6 | Angiopoietin-like 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
ANKDD1B | Ankyrin repeat and death domain containing 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKEF1 | Ankyrin repeat and EF-hand domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |